A whole-exome sequencing (WES) study was conducted in 3,233 cases diagnosed with multiple primary cancers and 3,229 matched cancer-free controls (90% non-Hispanic white, 3% African-American, 3% East A
We applied next generation sequencing technique to analyze the exome of a childhood treatment-related AML (tAML) patient and report isolation of multiple novel mutations in genes not previously associ
